Company Search:
Advanced Search
Sponsored Links
Valeant Pharmaceuticals International Inc Company Snapshot
Valeant Pharmaceuticals International Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valeant Pharmaceuticals International Inc with three other pharmaceutical manufacturers in North America: Mylan NV of the United States (2016 sales of $11.08 billion ), Shire PLC of the United States ($11.40 billion of which 100% was Pharmaceuticals & Genetic Therapies), and Celgene Corporation which is also based in the United States ($11.23 billion of which 100% was Biopharmaceuticals).

Sales Analysis. Valeant Pharmaceuticals International Inc reported sales of C$12.78 billion (US$10.02 billion) for the year ending December of 2016. This represents a decrease of 5.0% versus 2015, when the company's sales were C$13.46 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Valeant Pharmaceuticals International Inc
  Stock Performance Chart for Valeant Pharmaceuticals International Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 18.80
(Figures in Canadian Dollars)
1 Week -3.5%   13 Weeks 22.6%  
4 Weeks 4.0%   52 Weeks -22.8%  
Valeant Pharmaceuticals International Inc Key Data:
  Ticker: VRX Country: Canada
  Exchanges: NYSE TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 12,782,643,160
(Year Ending Jan 2017).
Employees: 21,500
  Currency: Canadian Dollars Market Cap: 6,553,352,053
  Fiscal Yr Ends: December Shares Outstanding: 348,582,556
  Share Type: Common Closely Held Shares: 3,700,501
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.